Tag Archives: Myriad

Myriad Brings Out Its “Reserve Claims” To Challenge Ambry

Posted on July 10, 2013 by Warren Woessner

In my post on this blog of June 17th, I speculated that the positive comments by the Supreme Court in the Myriad decision about the patent-eligibility of claims directed to new applications of natural products (like the BRCA genes) would … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

Association For Molecular Pathology V Myriad Genetics – An Isolated Local Difficulty?

Posted on June 14, 2013 by Warren Woessner

Paul Cole, Professor of Intellectual Property Law at Bournemouth University and European Patent Attorney at Lucas & Co, Warlingham, Surrey, UK discusses yesterdays Myriad ruling by the Supreme Court. How does yesterday’s Supreme Court decision match international opinion on the patentability … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Supreme Court Rules In Myriad On Patentability Of DNA

Posted on June 13, 2013 by Warren Woessner

Today, the Supreme Court ruled that a naturally occurring DNA sequence is a product of nature, and not patent-eligible simply because it has been “isolated.” (A copy of the ruling can be found at the end of this post.) However, the … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 4 Comments

Myriad Argued Before The Supreme Court – Some Snippets

Posted on April 17, 2013 by Warren Woessner

I confess that I’ve become addicted to this case and just finished all 63 pages of the transcript of the oral argument that took place on Monday. I won’t try to summarize it, but rather will try to review some … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment